Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

Frank L van de Veerdonk, Ilse J E Kouijzer, Aline H de Nooijer, Hans G van der Hoeven, Coen Maas, Mihai G Netea, Roger J M Brüggemann

Research output: Contribution to journalLetterAcademicpeer-review

2 Downloads (Pure)
Original languageEnglish
Article numbere2017708
JournalJAMA network open
Volume3
Issue number8
DOIs
Publication statusPublished - 13 Aug 2020

Keywords

  • Adult
  • Aged
  • Betacoronavirus
  • Bradykinin B2 Receptor Antagonists/therapeutic use
  • Bradykinin/analogs & derivatives
  • Coronavirus Infections/drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxygen/blood
  • Pandemics
  • Pneumonia, Viral/drug therapy
  • Receptor, Bradykinin B2/metabolism

Cite this